Author

Allan H. Barker

Observed names: A H Barker, Allan Barker, Allan H Barker

Observed institutions: National Institutes of Health, Vanderbilt University, University of Washington, University of Utah, Brown University, National Heart, Lung, and Blood Institute, Virginia Commonwealth University Medical Center

OpenAlex ID: A5007648288

Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo

1991 · Debra S. Echt, Philip R. Liebson, et al. · New England Journal of Medicine · 3,266

Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (The Cardiac Arrhythmia Pilot Study)

1989 · H.Leon Greene, David W. Richardson, et al. · The American Journal of Cardiology · 215

Beta-blocker therapy in the cardiac arrhythmia suppression trial

1994 · Harold L. Kennedy, Maria Mori Brooks, et al. · The American Journal of Cardiology · 172

Prognostic value of prolonged ventricular repolarization following myocardial infarction: The BHAT experience

1990 · Robert W. Peters, Robert P. Byington, et al. · Journal of Clinical Epidemiology · 94

Circadian pattern of arrythmic death in patients receiving encainide, Flecainide or moricizine in the cardiac arrhythmia

1994 · Robert W. Peters, Brent Mitchell, et al. · Journal of the American College of Cardiology · 55

Effects of Advancing Age on the Efficacy and Side Effects of Antiarrhythmic Drugs in Post‐Myocardial Infarction Patients with Ventricular Arrhythmias

1992 · Toshio Akiyama, Yudi Pawitan, et al. · Journal of the American Geriatrics Society · 52

Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study)

1989 · H.Leon Greene, David W. Richardson, et al. · The American Journal of Cardiology · 35

Prognostic significance of ventricular premature depolarizations measured 1 year after myocardial infraction in patient with early postinfarction asymptomatic ventricular arrhythmia

1992 · Alfred P. Hallstrom, J.Thomas Bigger, et al. · Journal of the American College of Cardiology · 33

Spontaneous variability in ventricular ectopic activity during chronic antiarrhythmic therapy.

1990 · J L Anderson, M I Anastasiou-Nana, et al. · Circulation · 22

Comparison of the antihypertensive effects of betaxolol to atenolol

1988 · William J. Mroczek, James F. Burris, et al. · The American Journal of Cardiology · 18

Relation of baseline characteristics to suppression of ventricular arrhythmias during placebo and active antiarrhythmic therapy in patients after myocardial infarction.

1989 · J L Anderson, A P Hallstrom, et al. · Circulation · 12

Mortality in the beta blocker heart attack trial: Circumstances surrounding death

1987 · Robert W. Peters, Robert Byington, et al. · Journal of Chronic Diseases · 8

Dissociation of lethal and nonlethal events in the cardiac arrhythmia suppression trial (CAST)

1991 · Debra S. Echt, Philip R. Liebson, et al. · Journal of the American College of Cardiology · 2

Variability in ventricular arrhythmias during chronic antiarrhythmic therapy: Role of baseline patient characteristics

1990 · Jeffrey L Anderson, Maria I Anastasiou-Nana, et al. · Journal of the American College of Cardiology

Works count: 14

Citation count: 3,984

H-index: 11

I10-index: 11